Skip to content
Screener

Microbot Medical MBOT Q2 2026 earnings

Reported August 11, 2026 · Before market open

Revenue$241.0KBeat by $107.7K
EPS-$0.08Miss by $0.00
Revenue estimate$133.3K
EPS estimate-$0.08

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$566.7K
EPS estimate-$0.09

Financials

Q2 2026

Income statement

See full
Revenue$241.0K—
Gross profit-$643.0K—
Operating income-$6.2M-66.2%
Net income-$5.6M-60.8%
EPS (diluted)-$0.08+20.0%

Balance sheet

See full
Cash & equivalents$3.4M-17.4%
Total debt$876.0K+488%
Total equity$68.9M+127%
Total assets$73.4M+121%

Cash flow

See full
Operating cash flow-$5.0M-93.9%
CapEx$142.0K+1,478%
Free cash flow-$5.1M-98.7%

Valuation & ratios

Valuation

as of 08/27/26
See full
Market cap$102.09M-44.9%
Enterprise value$99.55M-45.1%
P/S250.2×—

Returns & leverage

See full
Return on equity-32.9%-11.4pp
Debt / equity0×0.0×
Current ratio18.6×+6.5×

FAQ

When did Microbot Medical report Q2 2026 earnings?
Microbot Medical (MBOT) reported Q2 2026 earnings on August 11, 2026 before market open.
What were Microbot Medical's Q2 2026 revenue and EPS?
Microbot Medical reported revenue of $241.0K and eps of $-0.08 for Q2 2026.
Did Microbot Medical beat estimates in Q2 2026?
Revenue beat the consensus estimate of $133.3K by $107.7K. EPS missed the consensus estimate of $-0.08 by $0.00.
How did Microbot Medical's Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 20.0% from $-0.10.
Where can I find Microbot Medical's Q2 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-037031) and the 10-Q periodic report (0001493152-26-037009) directly on SEC EDGAR. The filing index links above go to sec.gov.